Cargando…

Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel

BACKGROUND: Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation process towards hypertrophy that limits their therapeutic efficacy. Matrix met...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahangir, Shahrbanoo, Eglin, David, Pötter, Naomi, Khozaei Ravari, Mojtaba, Stoddart, Martin J., Samadikuchaksaraei, Ali, Alini, Mauro, Baghaban Eslaminejad, Mohammadreza, Safa, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545577/
https://www.ncbi.nlm.nih.gov/pubmed/33036643
http://dx.doi.org/10.1186/s13287-020-01930-1
_version_ 1783592056081350656
author Jahangir, Shahrbanoo
Eglin, David
Pötter, Naomi
Khozaei Ravari, Mojtaba
Stoddart, Martin J.
Samadikuchaksaraei, Ali
Alini, Mauro
Baghaban Eslaminejad, Mohammadreza
Safa, Majid
author_facet Jahangir, Shahrbanoo
Eglin, David
Pötter, Naomi
Khozaei Ravari, Mojtaba
Stoddart, Martin J.
Samadikuchaksaraei, Ali
Alini, Mauro
Baghaban Eslaminejad, Mohammadreza
Safa, Majid
author_sort Jahangir, Shahrbanoo
collection PubMed
description BACKGROUND: Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation process towards hypertrophy that limits their therapeutic efficacy. Matrix metallopeptidase 13 (MMP-13) is a well-known factor regulated during this undesirable event. MMP-13 is a collagen degrading enzyme, which is also highly expressed in the hypertrophic zone of the growth plate and in OA cartilage. Accordingly, we investigated the effect of MMP-13 inhibition on MSC hypertrophy. METHODS: In this study, 5-bromoindole-2-carboxylic acid (BICA) was used as an inhibitory agent for MMP-13 expression. After identifying its optimal concentration, BICA was mixed into a hydrogel and the release rate was studied. To prepare the ideal hydrogel, chondroitin sulfate (CS) and platelet lysate (PL) were mixed with sodium alginate (Alg) at concentrations selected based on synergistic mechanical and rheometric properties. Then, four hydrogels were prepared by combining alginate (1.5%w/v) and/or CS (1%w/v) and/or PL (20%v/v). The chondrogenic potential and progression to hypertrophy of human bone marrow-derived mesenchymal stem cell (hBM-MSC)-loaded hydrogels were investigated under free swelling and mechanical loading conditions, in the presence and absence of BICA. RESULTS: Viability of hBM-MSCs seeded in the four hydrogels was similar. qRT-PCR revealed that BICA could successfully inhibit MMP-13 expression, which led to an inhibition of Coll X and induction of Coll-II, in both free swelling and loading conditions. The GAG deposition was higher in the group combining BICA and mechanical stimulation. CONCLUSIONS: It is concluded that BICA inhibition of MMP-13 reduces MSC hypertrophy during chondrogenesis. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-7545577
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75455772020-10-13 Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel Jahangir, Shahrbanoo Eglin, David Pötter, Naomi Khozaei Ravari, Mojtaba Stoddart, Martin J. Samadikuchaksaraei, Ali Alini, Mauro Baghaban Eslaminejad, Mohammadreza Safa, Majid Stem Cell Res Ther Research BACKGROUND: Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation process towards hypertrophy that limits their therapeutic efficacy. Matrix metallopeptidase 13 (MMP-13) is a well-known factor regulated during this undesirable event. MMP-13 is a collagen degrading enzyme, which is also highly expressed in the hypertrophic zone of the growth plate and in OA cartilage. Accordingly, we investigated the effect of MMP-13 inhibition on MSC hypertrophy. METHODS: In this study, 5-bromoindole-2-carboxylic acid (BICA) was used as an inhibitory agent for MMP-13 expression. After identifying its optimal concentration, BICA was mixed into a hydrogel and the release rate was studied. To prepare the ideal hydrogel, chondroitin sulfate (CS) and platelet lysate (PL) were mixed with sodium alginate (Alg) at concentrations selected based on synergistic mechanical and rheometric properties. Then, four hydrogels were prepared by combining alginate (1.5%w/v) and/or CS (1%w/v) and/or PL (20%v/v). The chondrogenic potential and progression to hypertrophy of human bone marrow-derived mesenchymal stem cell (hBM-MSC)-loaded hydrogels were investigated under free swelling and mechanical loading conditions, in the presence and absence of BICA. RESULTS: Viability of hBM-MSCs seeded in the four hydrogels was similar. qRT-PCR revealed that BICA could successfully inhibit MMP-13 expression, which led to an inhibition of Coll X and induction of Coll-II, in both free swelling and loading conditions. The GAG deposition was higher in the group combining BICA and mechanical stimulation. CONCLUSIONS: It is concluded that BICA inhibition of MMP-13 reduces MSC hypertrophy during chondrogenesis. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2020-10-09 /pmc/articles/PMC7545577/ /pubmed/33036643 http://dx.doi.org/10.1186/s13287-020-01930-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jahangir, Shahrbanoo
Eglin, David
Pötter, Naomi
Khozaei Ravari, Mojtaba
Stoddart, Martin J.
Samadikuchaksaraei, Ali
Alini, Mauro
Baghaban Eslaminejad, Mohammadreza
Safa, Majid
Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
title Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
title_full Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
title_fullStr Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
title_full_unstemmed Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
title_short Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
title_sort inhibition of hypertrophy and improving chondrocyte differentiation by mmp-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545577/
https://www.ncbi.nlm.nih.gov/pubmed/33036643
http://dx.doi.org/10.1186/s13287-020-01930-1
work_keys_str_mv AT jahangirshahrbanoo inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT eglindavid inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT potternaomi inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT khozaeiravarimojtaba inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT stoddartmartinj inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT samadikuchaksaraeiali inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT alinimauro inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT baghabaneslaminejadmohammadreza inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel
AT safamajid inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel